Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of typical chemotherapeutics among cancer survivors. Despite the recent progress, the effective prevention and treatment strategies for CIPN remain limited. Better understanding of the pathogenesis of CIPN may provide new nich...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Chih-Hung, Lin, Yuan-Ho, Li, Yung-Sheng, Ho, Trung-Loc, Hoai Thuong, Le Huynh, Liu, Yu-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430591/
https://www.ncbi.nlm.nih.gov/pubmed/34502166
http://dx.doi.org/10.3390/ijms22179257
Descripción
Sumario:Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of typical chemotherapeutics among cancer survivors. Despite the recent progress, the effective prevention and treatment strategies for CIPN remain limited. Better understanding of the pathogenesis of CIPN may provide new niches for developing a new ideal therapeutic strategy. This review summarizes the current understanding of CIPN and current recommendations along with completed/active clinical trials and aims to foster translational research to improve the development of effective strategies for managing CIPN.

Ejemplares similares